Jonas W. Wastesson

2.1k total citations · 2 hit papers
53 papers, 1.3k citations indexed

About

Jonas W. Wastesson is a scholar working on Geriatrics and Gerontology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Jonas W. Wastesson has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Geriatrics and Gerontology, 19 papers in General Health Professions and 17 papers in Economics and Econometrics. Recurrent topics in Jonas W. Wastesson's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Health disparities and outcomes (10 papers). Jonas W. Wastesson is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Health disparities and outcomes (10 papers). Jonas W. Wastesson collaborates with scholars based in Sweden, Denmark and Australia. Jonas W. Wastesson's co-authors include Kristina Johnell, Lucas Morin, Edwin C.K. Tan, Johan Fastbom, Marie‐Laure Laroche, Marti G. Parker, Mats Thorslund, Ingemar Kåreholt, Stefan Fors and Michael Crowe and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Cancer.

In The Last Decade

Jonas W. Wastesson

46 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An update on the clinical consequences of polypharmacy in older adults: a narrative review

2018 349 citations Jonas W. Wastesson, Lucas Morin et al. profile →
The epidemiology of polypharmacy in older adults: register-based prospective cohort study

2018 244 citations Lucas Morin, Kristina Johnell et al. Clinical Epidemiology profile →

Peers

Jonas W. Wastesson

CCM

GHP

Anna Renom‐Guiteras Spain

Denys T. Lau United States

Sven Streit Switzerland

Lisa McCarthy Canada

Todd P. Semla United States

Ulrike Junius‐Walker Germany

Elizabeth Lenaghan United Kingdom

Amanda Lavan Ireland

Beatrice Gasperini Italy

Renate Quinzler Germany

Anna Renom‐Guiteras Spain

Jonas W. Wastesson

654 ×0.9

316 ×0.7

154 ×0.5

CCM

427 ×1.9

GHP

214 ×1.1

Citations per year, relative to Jonas W. Wastesson Jonas W. Wastesson (= 1×) peers Anna Renom‐Guiteras

Countries citing papers authored by Jonas W. Wastesson

Since Specialization

Citations

This map shows the geographic impact of Jonas W. Wastesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas W. Wastesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas W. Wastesson more than expected).

Fields of papers citing papers by Jonas W. Wastesson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas W. Wastesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas W. Wastesson. The network helps show where Jonas W. Wastesson may publish in the future.

Co-authorship network of co-authors of Jonas W. Wastesson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas W. Wastesson. A scholar is included among the top collaborators of Jonas W. Wastesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas W. Wastesson. Jonas W. Wastesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khalili, Hamed, Emma E. McGee, Björn Roelstraete, et al.. (2025). Medications and Risk for Microscopic Colitis: A Nationwide Study of Older Adults in Sweden. Annals of Internal Medicine. 178(8). 1106–1115.

Wastesson, Jonas W., et al.. (2025). The Prevalence of Polypharmacy and the Contribution of Age, Period, and Cohort Effects in Sweden From 2006 to 2020. Health Science Reports. 8(5). e70778–e70778.

Wastesson, Jonas W., et al.. (2025). Studying Deprescribing Using Routinely Collected Healthcare Data: Old Challenges and New Opportunities. Basic & Clinical Pharmacology & Toxicology. 137(5). e70131–e70131.

Maura, Géric, Jani Raitanen, Leena Forma, et al.. (2024). Long-term care use, hospitalizations and mortality during COVID-19 in Finland and Sweden: A nationwide register-based study in 2020. Scandinavian Journal of Public Health. 52(3). 345–353. 2 indexed citations

Wastesson, Jonas W., et al.. (2024). Trends in Drug Duplications in Swedish Older Adults: A Nationwide Register Study from 2006 to 2021. Drugs & Aging. 41(9). 775–781. 1 indexed citations

Trevisan, Caterina, Lu Dai, Amaia Calderón‐Larrañaga, et al.. (2024). Comorbidity patterns and the risk of injurious falls in older people with atrial fibrillation: Findings from a Swedish nation-wide population-based study. European Journal of Internal Medicine. 132. 97–105. 2 indexed citations

Vetrano, Davide Liborio, Lu Dai, Amaia Calderón‐Larrañaga, et al.. (2024). Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study. Frontiers in Pharmacology. 15. 1476464–1476464. 3 indexed citations

Bliddal, Mette, Øystein Karlstad, Jonas W. Wastesson, et al.. (2024). Comparison of sociodemographic factors, healthcare utilisation by general practitioner visits, somatic hospital admissions, and medication use in Norway, Sweden, and Denmark. Annals of Epidemiology. 98. 1–7. 2 indexed citations

Tang, Bowen, Arvid Sjölander, Jonas W. Wastesson, et al.. (2024). Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study. EClinicalMedicine. 73. 102689–102689. 26 indexed citations

10.

Dai, Lu, Hao Luo, Jonas W. Wastesson, et al.. (2023). Comorbidity patterns and health-related outcomes in older adults with atrial fibrillation: nationwide population-based findings from swedish national patient register. European Heart Journal. 44(Supplement_2). 1 indexed citations

11.

Wastesson, Jonas W., Johan Fritzell, Bo Burström, Kristina Johnell, & Johan Fastbom. (2023). Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020. Frontiers in Pharmacology. 14. 2 indexed citations

12.

Kelfve, Susanne, Jonas W. Wastesson, & Bettina Meinow. (2023). Length of the period with late life dependency: Does the age of onset make a difference?. European Journal of Ageing. 20(1). 30–30. 2 indexed citations

13.

Nilsen, Charlotta, Janne Agerholm, Susanne Kelfve, et al.. (2023). History of working conditions and the risk of old-age dependency: a nationwide Swedish register-based study. Scandinavian Journal of Public Health. 52(6). 726–732.

14.

Højlund, Mikkel, Lárus S. Guðmundsson, Jacob Harbo Andersen, et al.. (2022). Use of benzodiazepines and benzodiazepine‐related drugs in the Nordic countries between 2000 and 2020. Basic & Clinical Pharmacology & Toxicology. 132(1). 60–70. 15 indexed citations

15.

Wastesson, Jonas W., et al.. (2021). Unplanned hospitalisations in older people: illness trajectories in the last year of life. BMJ Supportive & Palliative Care. 14(e1). e953–e961. 5 indexed citations

16.

Agahi, Neda, et al.. (2021). Increasing inequalities in disability-free life expectancy among older adults in Sweden 2002–2014. Scandinavian Journal of Public Health. 51(6). 835–842. 10 indexed citations

17.

Tan, Edwin C.K., Janet K. Sluggett, Kristina Johnell, et al.. (2018). Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus. Journal of the American Medical Directors Association. 19(3). 193–199. 37 indexed citations

18.

Morin, Lucas, Kristina Johnell, Marie‐Laure Laroche, Johan Fastbom, & Jonas W. Wastesson. (2018). The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clinical Epidemiology. Volume 10. 289–298. 244 indexed citations breakdown →

19.

Wastesson, Jonas W., Vladimir Canudas‐Romo, Rune Lindahl‐Jacobsen, & Kristina Johnell. (2015). Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older. Journal of the American Medical Directors Association. 17(1). 31–35. 31 indexed citations

20.

Wastesson, Jonas W., Marcie Parker, Johan Fastbom, Mats Thorslund, & Kristina Johnell. (2011). Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study. Age and Ageing. 41(2). 218–224. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact